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SUMMARY – The APACHE II scoring system is approved for its benchmarking and mortality 
predictions, but there are only a few articles published to demonstrate it in neurosurgical patients. 
Therefore, this study was performed to acknowledge this score and its predictive performance to hos-
pital mortality in a tertiary referral neurosurgical intensive care unit (ICU). All patients admitted to 
the Neurosurgical ICU from February 1 to July 31, 2011 were recruited. The parameters indicated in 
APACHE II score were collected. The adjusted predicted risk of death was calculated and compared 
with the death rate observed. Descriptive statistics including the receiver operating characteristic 
curve (ROC) was performed. The results showed that 276 patients were admitted during the men-
tioned period. The APACHE II score was 16.56 (95% CI, 15.84-17.29) and 19.08 (95% CI, 15.40-
22.76) in survivors and non-survivors, while the adjusted predicted death rates were 13.39% (95% CI, 
11.83-14.95) and 17.49% (95% CI, 9.81-25.17), respectively. The observed mortality was only 4.35%. 
The area under the ROC of APACHE II score to the hospital mortality was 0.62 (95% CI, 0.44-
0.79). In conclusion, not only the APACHE II score in neurosurgical patients indicated low severity, 
but its performance to predict hospital mortality was also inferior. Additional studies of predicting 
mortality among these critical patients should be undertaken.
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Introduction
In the era of quality-based medicine, high-risk 
neurosurgical patients represent a considerable pro-
portion of intensive care unit (ICU) admissions aim-
ing to fulfill the gap of treatment standard and expect-
ing the best clinical outcome. However, some recent 
studies showed the mortality in neurosurgical ICU to 
be three times higher than in general ICU, accounting 
for 22.5%-24.8% of the in-hospital mortality and 
39.8% of the mortality after 1 year1-3. Information de-
rivable from effective mortality predicting tools may 
facilitate the appropriate administrative management 
rationale among the scarcity of healthcare resources 
and help guiding physician for proper evidence-based 
decision-making.
A widely used ICU prognostic scoring model, the 
Acute Physiology and Chronic Health Evaluation II 
(APACHE II) scoring system has been recognized. It 
has shown to be an accurate measurement of patient 
severity and correlates strongly with outcome in criti-
cal patients4,5. The highly differentiated affinity among 
critically ill patients was shown by the AUC of 0.806-
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0.8926-9. The familiarity is achieved because of its less 
variables and no calculation converted for any sea lev-
els affected4,10. The APACHE II score can compare 
and benchmark for the effectiveness, efficacy and qual-
ity matter of each unit individually11,12. Nonetheless, 
the qualified systematic database indicating APACHE 
II score, i.e. patient diagnosis, clinical condition, scien-
tific parameters and laboratory values could hardly be 
established in routine13,14. Particularly in fragile neuro-
surgical patients, the clinical condition may alter and 
need specific treatment immediately.
The length of stay is one of the most concerned is-
sues not only for the healthcare personnel but also the 
patients, relatives and health insurance providers15. 
Some literature data indicate that the mean length of 
ICU stay is 4.5-6.0 days for the patient undergoing 
craniotomy with blood clot removal, 1.8-2.9 days for 
the patient undergoing craniotomy without blood clot 
removal, and 11.2±15.4 days for stroke patients16. 
However, there is still no strong evidence supporting 
the validity of the length of hospital stay estimators in 
these groups of patients.
From the critical appraisal process, few articles re-
viewed the value of APACHE II score and perfor-
mance of mortality prediction in subspecialty ICUs 
that have different case-mix and different provider-
mix such as neurosurgical ICU3. The discordance be-
tween the predictive implications, particularly on some 
specific neurosurgical disease conditions that were not 
generalized to the others, was mentioned17. Therefore, 
this retrospective study was performed to present the 
severity of illness by acknowledging the APACHE II 
score among neurosurgical ICU patients, to predict 
mortality reflecting APACHE II performance, and 
to evaluate the relationship of APACHE II score pa-
rameters as if they could estimate the length of hospi-
tal stay.
Patients and Methods
This study had been registered at the Thai Clinical 
Trials Registry with the identification number of 
TCTR 20150925001. Approval for the study (No. 
10/2555) was received from the Prasat Neurological 
Institutional Ethics Committee (Chairman: Suchart 
Hanchaipiboonkul) on February 8, 2012, and written 
informed consent was obtained from all patients or le-
gal relatives in case of unconsciousness. All patients 
admitted to neurosurgical ICU at Prasat Neurological 
Institute, Bangkok, between February 1 and July 31, 
2011 were recruited. Demographics and the parame-
ters indicating APACHE II score were collected with-
in 30 minutes after admission by certified neurosurgi-
cal registrar nurses. The score calculation software was 
developed based on Microsoft Excel 2007 software 
(Seattle, WA, 2007) to convert those parameters, i.e. 
body temperature, mean arterial pressure, heart rate, 
respiratory rate, alveolar-arterial oxygen (A-a) gradi-
ent; if fractional inspired oxygen concentration is ≥0.5, 
arterial oxygen tension (PaO2); if fractional inspired 
oxygen concentration is <0.5, serum bicarbonate 
(HCO3); if there is no arterial blood gas analysis, arte-
rial pH, serum sodium, serum potassium, creatinine, 
hematocrit, white blood cell count, Glasgow Coma 
Scale score, age and medical condition were entered 
into the APACHE II score, as shown in Figure 14. The 
adjusted predicted risk of death (R) for each patient 
was calculated based on the patient’s APACHE diag-
nosis, APACHE II score, and surgical status by using 
the APACHE II risk of death equation [ln (R/1-
R)=-3.517 + (APACHE II score x 0.146) + (0.603, 
only if postoperative emergency surgery) + (diagnostic 
category weight, as indicated in listing of diagnostic 
categories leading to ICU admission)]4. The length of 
stay and Glasgow Outcome Scale score were also re-
corded at unit discharge and hospital discharge. The 
observed death rate was compared with the risk-ad-
justed death prediction for the study population.
This retrospective study was performed within a 
6-month period, expected to recruit 250 patients at 
least. The NQuery Advisor software version 6.0 (Bos-
ton, MA, 2005) was calculated to reassure the power of 
this study according to Park et al.3, which showed the 
adjusted predicted mortality rate in neurosurgical ICU. 
Finally, it was found that the power would increase to 
99% if capable to detect the difference between the 
null hypothesis proportion of 0.38 and the alternative 
proportion of 0.25, with the sample size of 228, a sin-
gle group t-test with a 0.05 two-sided significance 
level.
For demographic data, descriptive statistics was 
used and reported as mean, standard deviation (SD), 
95% confidence interval (95% CI), number and per-
cent. The area under the receiver operating characteris-
tic curve (AUC) was analyzed, as well as the optimal 
cut point to demonstrate the capability of APACHE 
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Fig. 1. Summary variables and calculation methods for Acute Physiology  
and Chronic Health Evaluation (APACHE) II score.
Physiologic Variable Points+4 +3 +2 +1 0 +1 +2 +3 +4
 1. Temperature (°C) ≥41 39-40.9 38.5-38.9 36-38.4 34-35.9 32-33.9 30-31.9 ≤29.9
 2.  Mean arterial pressure 
(mmHg) ≥160 130-159 110-129 70-109 50-69 ≤49
 3. Heart rate (/min) ≥180 140-179 110-139 70-109 55-69 40-54 ≤39
 4. Respiratory rate (/min) ≥50 35-49 25-34 12-24 10-11 6-9 ≤5
 5. Oxygenation (mmHg)
a. A-aDO2 if FiO2 ≥0.5
b. PaO2 if FiO2 <0.5
500 350-499 200-349 <200
>70 61-70 55-60 <55
 6. Acid-base balance
a. Arterial pH
b.  Serum HCO3 (mEq/l) 















 7. Sodium (mEq/l) ≥180 160-179 155-159 150-154 130-149 120-129 111-119 ≤110
 8. Potassium (mEq/l) ≥7 6-6.9 5.5-5.9 3.5-5.4 3-3.4 2.5-2.9 <2.5
 9. Creatinine (mg/dl) ≥3.5 2-3.4 1.5-1.9 0.6-1.4 <0.6
10. Hematocirt (%) ≥60 50-59.9 46-49.9 30-45.9 20-29.9 <2.5
11.  White blood count 
(×1000/mm3) ≥40 20-39.9 15.19.9 3-14.9 1-2.9 <1
12.  Glasgow Coma Score 
(GCS) Score = 15 minus actual GCS
A. Total Acute Physiology Score (sum of 12 above points)
B. Age points (years) ≤44=0; 45 to 54=2; 55 to 64=3; 65 to 74=5; ≥75=6
C. Chronic Health Points*
Total APACHE II Score (add together the points from A+B+C)
* Chronic Health Points: If the patient has a history of severe organ system insufficiency or is immune-compromised as defined below, as-
sign points as follows:
5 points for non-operative or emergency post-operative patients
2 points for elective post-operative patinets
II score to predict death rate. Pearson’s correlation was 
conducted using the SPSS software version 16 
(Markham, Ontario, Canada, 2007) to determine the 
correlation of APACHE II score and the length of 
stay. If the correlation is over 0.8 at p-value <0.05, the 
predictive property of APACHE II parameters and 
the length of stay are further analyzed with the gen-
eral linear model. The values were expressed as mean 
difference and 95% CI.
Results
There were 276 patients admitted to the neurosur-
gical ICU, mean age ± SD 47.94±15.39 years. Of these, 
246 (89.13%) were elective cases and 30 (10.87%) 
were emergency cases. Two hundred and fifty-eight 
(93.48%) patients were transferred from the operating 
theater, 12 (4.35%) from hospital ward, and six (2.17%) 
from outside the hospital. Demographics and patient 
characteristics are shown in Table 1.
Arterial blood gas analyses were performed com-
pletely in all 276 patients. Only two in the cerebral 
tumor and two in cerebral vascular lesion categories 
had received high concentration of oxygen (FiO2 >0.5), 
showing a mean A-a gradient of 178.85±67.49 mm 
Hg. The incidence of acute renal failure and comor-
bidities indicating chronic health points, i.e. AIDS, he-
patic failure, lymphoma, metastasis cancer, leukemia, 
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immune compromise and cirrhosis were not identified. 
The APACHE II parameters are shown in Table 2.
There was no death at ICU discharge, while 
Glasgow Outcome Scale scores 2-5 (persistent vegeta-
tive state to good recovery) were recorded in one 
(0.36%), 14 (5.07%), 77 (27.90%) and 184 (66.67%) 
patients, respectively. At hospital discharge, 12 (4.35%) 
patients died. Of the 264 (95.65%) survivors, one 
(0.36%) had persistent vegetative state, seven (2.54%) 
were conscious but disabled, 42 (15.22%) were dis-
abled but independent, and 214 (77.54%) had good 
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Table 2. Values of Acute Physiology and Chronic Health 
Evaluation (APACHE) II variables

















































MAP = mean arterial pressure; RR = respiratory rate; GCS = 
Glasgow Coma Score
Fig. 2. Hospital mortality categorized by Acute Physiology  
and Chronic Health Evaluation (APACHE) II score.
P. Akavipat et al. The low performance scale in Neuro-ICU
54 Acta Clin Croat, Vol. 58, No. 1, 2019
recovery and were capable to return to their way of life. 
The overall APACHE II score in survivors and non 
survivors was 16.56±5.95 (95% CI, 15.84-17.29) and 
19.08±6.47(95% CI, 15.40-22.76), while the calculat-
ed APACHE II adjusted predicted mortality was 
13.39±12.85% (95% CI, 11.83-14.95) and 17.49± 
13.51% (95% CI, 9.81-25.17), respectively. The 
APACHE II score and hospital mortality are summa-
rized in Figure 2.
The AUC of APACHE II score to hospital mor-
tality was 0.62 (95% CI, 0.44-0.79), as shown in Fig-
ure 3. Finally, the optimal cut point of 18 would yield 
the sensitivity of 58.33% (95% CI, 52.52-64.15) and 
specificity of 61.36% (95% CI, 55.62-67.11).
tiary referral neurosurgical center. Nevertheless, the 
mortality and length of hospital stay prediction was 
not achieved by APACHE II model.
For the performance of mortality prediction, the 
APACHE II scale has been validated and accepted in 
many settings of general ICU, with the AUC varying 
from 0.74 to 0.8617-21. The risk-adjusted formula to 
predict mortality estimated from APACHE II score is 
a remarkable advantage18,19. The diagnostic category 
weight variables, e.g., the causes of respiratory failure, 
the causes of cardiovascular failure, the major vital or-
gan surgeries leading to ICU admission post-surgery, 
type of surgery, etc., were included4,22. However, the 
adjusted predicted values were not related to the ob-
served mortality and could not discriminate between 
survivors and non-survivors in neurosurgical ICU. The 
possibility of monitoring modality, the effectiveness of 
multidisciplinary team, therapeutic preference and pa-
tient unique characteristics were considered, in partic-
ular patient distinctive nature, disease specific pathol-
ogy, and severity of illness23,24.
Besides the property of APACHE II score in mor-
tality prediction, determining the length of hospital-
ization was also expected. This study showed a nonsig-
nificant correlation between the scores and the length 
of hospital stay. Interestingly, even the length of ICU 
stay was longer than in an earlier study but when com-
pared to general ICU, it was still shorter25. This result 
is in contrast to the study by Rubiano et al., who report 
that the length of stay in teaching hospitals is longer 
because they need more time to investigate and take 
care specifically26.
The practical reason that was different from the 
others was the primary patient condition. Most of the 
patients admitted to neurological ICU in this setting 
were healthy or were partially treated before their 
transfer. Ninety-three percent of the patients were ad-
mitted with the criterion of postoperative major neu-
rosurgery without any other complications. In fact, the 
term ‘High Dependency Care Unit’ may be used prop-
erly instead of the term ‘Intensive Care Unit’ in these 
circumstances27. Moreover, this unit has been orga-
nized as an open intensive care system. The responsible 
physician is a neurosurgeon appointed on the bed 
quota basis, which resulted in a lower and wider range 
of APACHE II scores (6-39 score of 0-67 total score).
Our study had several limitations. Firstly, we used 
an ICU to take care of postoperative patients that were 
Fig. 3. The receiver operating characteristic curve of the 
Acute Physiology and Chronic Health Evaluation 
(APACHE) II score.
Seventeen patients had total length of hospital stay 
of over 114 days. The mean ± SD and median (min-
max) for total length of hospital stay were 32.37±65.57 
days and 12 (2-535) days, while the mean ± SD and 
median (min-max) for the length of ICU stay were 
2.55±2.51 days and 2 (1-25) days, respectively.
The correlation of APACHE II score with the 
length of ICU stay (r2=0.12 with 95% CI 0.00-0.23; 
p=0.036) and length of hospital stay (r2=0.07 with 95% 
CI, 0.05-0.19; p=0.24) was nonsignificant.
Discussion
This study demonstrated the severity of patient 
conditions in neurosurgical ICU in terms of APACHE 
II score, which probably reflects the spectrum of a ter-
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healthy and most of them did not have any other com-
plications. Despite this, the APACHE II score is less 
likely to represent the severity of the real situation. We 
would recommend re-estimation of the patients ac-
cording to the admission criteria if applied to a na-
tional sample. Secondly, our hospital sample had a lim-
ited number of performance outliers because it is a 
tertiary referral healthcare center. There were a few 
cases of traumatic brain injury or emergency situation. 
A larger sample of cases is needed to draw more reli-
able conclusions in these circumstances. Thirdly, there 
was a limitation of the assessment frequency, as even 
the criteria of APACHE II evaluation were recom-
mended to be measured once within 24 hours of ad-
mission but the estimated accuracy would be increased 
if the assessment could have been performed periodi-
cally.
In conclusion, the mean APACHE II score in neu-
rosurgical ICU patients was 16.67±5.99 (95% CI, 
15.96-17.38). The calculated adjusted predicted mor-
tality was 13.57±12.88% (95% CI, 12.04-15.09), while 
the hospital-discharge mortality was only 4.35%. We 
found that the mortality predictive performance of 
APACHE II score was not precise. Nevertheless, these 
results can provide general informative data to the 
benefit of setting standard clinical indicators individu-
ally and initiate liberal study of the mortality predictor 
in these critical patients in the future.
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Sažetak
SUSTAV APACHE II. KAO KLINIČKI PREDIKTOR  
U NEUROKIRURŠKOJ JEDINICI INTENZIVNOG LIJEČENJA
P. Akavipat, J. Thinkhamrop, B. Thinkhamrop i W. Sriraj
Sustav APACHE II. odobren je kao mjerilo i prediktor smrtnosti, no samo se nekoliko članaka bavi njegovom primje-
nom kod neurokirurških bolesnika. Stoga smo proveli ovo istraživanje kako bismo potvrdili ovaj sustav i njegovu sposobnost 
predviđanja bolničke smrtnosti u referentnoj tercijarnoj neurokirurškoj jedinici intenzivnog liječenja ( JIL). U istraživanje su 
bili uključeni svi bolesnici primljeni u neurokiruršku JIL od 1. veljače do 31. srpnja 2011. godine. Prikupljeni su podaci koji 
se odnose na parametre sustava APACHE II. Izračunat je prilagođeni rizik smrti i uspoređen sa zabilježenom stopom smrt-
nosti. U analizi je primijenjena deskriptivna statistika uključujući ROC. Rezultati su pokazali da je primljeno 276 bolesnika. 
Zbir APACHE II. bio je 16,56 (95% CI, 15,84-17,29) za preživjele i 19,08 (95% CI, 15,40-22,76) za umrle, dok je prilago-
đena predviđena stopa smrtnosti bila 13,39% (95% CI, 11,83-14,95) odnosno 17,49% (95% CI, 9,81-25,17). Zabilježena 
stopa smrtnosti bila je samo 4,35%. Područje ispod ROC zbira APACHE II. za bolničku smrtnost iznosila je 0,62 (95% CI, 
0,44-0,79). U zaključku, ne samo da je zbir APACHE II. pokazao nisku težinu kod neurokirurških bolesnika, nego je i nje-
gov rezultat u predviđanju bolničke smrtnosti bio nezadovoljavajući. Treba provesti daljnja istraživanja prediktora smrtnosti 
kod ovih kritičnih bolesnika.
Ključne riječi: APACHE; Bolnička smrtnost; Dužina hospitalizacije; Stupanj težine bolesti; Jedinice intenzivne skrbi
